GlassScriptPhysician profile
Eric Phililp Stander
NPI 1861441636
$9,359.16
in general payments reported to CMS, 2019-2025
17 companies · $70.05 in 2025
The $70.05 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,064 · 2020: $58.83 · 2021: $335 · 2022: $314 · 2023: $223 · 2024: $294 · 2025: $70.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $8,051.97 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $521.44 | 2020-2024 | Andexxa |
| Fisher & Paykel Healthcare INC | $130.33 | 2024 | Fisher & Paykel Healthcare |
| Boston Scientific Corporation | $115.91 | 2021 | |
| Bioxcel Therapeutics, INC. | $115.26 | 2024 | Igalmi |
| Kedrion Biopharma, INC. | $86.87 | 2022 | |
| Abbvie INC. | $86.84 | 2022-2025 | |
| Shionogi INC | $78.12 | 2023 | Fetroja |
| Vapotherm INC | $58.03 | 2021-2022 | |
| Rare Disease Therapeutics, INC. | $15.79 | 2021 | |
| Grifols USA, LLC | $15.78 | 2025 | Hyperrab |
| Pfizer INC. | $14.99 | 2020 | |
| Nabriva Therapeutics, Plc | $14.80 | 2020 | |
| Csl Behring | $14.69 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.38 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $12.30 | 2021 | |
| Mallinckrodt Enterprises LLC | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Stander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.